Head to head
PlexusDx vs Hims
These two are not the same purchase. PlexusDx supplies compounded medication; Hims supplies FDA-approved drugs only. Everything below is from the record, and every regulatory action links to its document.
- PlexusDx
- Compounded
$99/mo - Hims
- FDA-approved
$149/mo - PlexusDx on file
- 0
- Hims on file
- 4
Side by side
What each one publishes about itself
Every figure here is the provider’s own advertised number, not an estimate. A dash means the company does not publish it.
| PlexusDx | Hims | |
|---|---|---|
| Supplies | Compounded only | FDA-approved medication only |
| Advertised from | $99/mo | $149/mo |
| Compounded semaglutide, per month | $99/mo 12-month plan, $1,188 up front ($109 on 6 months, $129 on 3, $149 month to month); injection or tablet (read 2026-11-16) | Not verified |
| Compounded tirzepatide, per month | $129/mo 12-month plan; injection or tablet (read 2026-11-16) | Not verified |
| First month | — | $39 |
| Medication in the price | Included | Billed separately |
| Insurance | Cash pay | Cash pay |
| Intake | Labs | Async |
| Dose pricing | Check at intake | Check at intake |
| Named 503A/503B pharmacy | Not named pre-intake | Not named pre-intake |
| On the record | Nothing found | 4 actions |
PlexusDx
Compounded only, from $99 a month. Nothing found on record. The link below is an affiliate link and pays us a commission; it changed nothing above.
Hims
FDA-approved medication only, from $149 a month. 4 actions on record, each linked on its page. The link below earns us nothing.
Compare PlexusDx & Hims against zero-action peers
Verified providers in the same category with 0 regulatory actions on file and published monthly pricing:
The difference that actually matters
PlexusDx supplies compounded semaglutide or tirzepatide: medication prepared by a compounding pharmacy rather than an FDA-approved product. Cheaper, legal, and the category the FDA has been issuing warning letters about since September 2025.
Hims supplies the approved drugs and nothing else, which puts it outside compounding enforcement entirely, which is a large part of why it costs what it costs.
What is on Hims’s record
2025-09
FDA warning letter to Hims & Hers Health, Inc. dba Hims (MARCS-CMS 716567) over compounded GLP-1 marketing.
2026-03
Novo Nordisk sued Hims & Hers for infringement of US Patent 8,129,343 in the District of Delaware on 9 February 2026 (No. 1:26-cv-00143) and voluntarily dismissed it without prejudice on 9 March 2026, expressly reserving the right to refile, under an agreement in which Hims & Hers stopped advertising compounded GLP-1s and began distributing Novo's FDA-approved semaglutide.
2026-07
The FTC, the State of Utah and Los Angeles County sued Hims & Hers Health, Inc. in the Northern District of California under FTC Act section 5 and ROSCA, alleging the company disclosed customers' health information to advertising platforms including Meta and Snap, charged consumers before the promised provider consultation, and obstructed cancellation; allegations unproven.
Go direct
Both companies, and what we earn from each
We do not recommend one over the other. Where a link pays us, it says so here and on the provider’s own page.
PlexusDx
Compounded only, from $99 a month. Nothing found on record. The link below is an affiliate link and pays us a commission; it changed nothing above.
Hims
FDA-approved medication only, from $149 a month. 4 actions on record, each linked on its page. The link below earns us nothing.
Long-form provider files
Full price tables, terms and records
Every plan length, the refund and cancellation terms, named pharmacies, review-site links and each regulatory action with its primary document. These 6 providers pay us a referral commission if you sign up through our links; ordered by lowest verified monthly price only.
| Provider file | Sema. /mo | Tirz. /mo | Actions on file | Links |
|---|---|---|---|---|
| Embody | $49 | $99 | None | Read the dossier →Embody site ↗ |
| Belle | $93 | $149 | 1 | Read the dossier →Belle site ↗ |
| PlexusDx | $99 | $129 | None | Read the dossier →PlexusDx site ↗ |
| MEDGm | $169 | $269 | None | Read the dossier →MEDGm site ↗ |
| DirectMeds | $249 | $399 | 1 | Read the dossier →DirectMeds site ↗ |
| GoodLife Health | $299 membership | + brand-name drug | None | Read the dossier →GoodLife Health site ↗ |
- Embodyfrom $49/moSema. $49 · Tirz. $99None on file
- Bellefrom $93/moSema. $93 · Tirz. $1491 on file
- PlexusDxfrom $99/moSema. $99 · Tirz. $129None on file
- MEDGmfrom $169/moSema. $169 · Tirz. $269None on file
- DirectMedsfrom $249/moSema. $249 · Tirz. $3991 on file
- GoodLife Healthfrom $299/mo + drugMembership; brand-name drug billed separatelyNone on file
Each row has two links: “Read the dossier” opens our file on that provider, and the “site ↗” button opens the provider’s own site in a new tab. Nothing else in the row is a link. Where a provider runs an affiliate programme with us, its site button is a referral link and we may earn a commission at no cost to you. It never changes the order or what is on file.
Straight answers
PlexusDx vs Hims, in short
- Is PlexusDx or Hims cheaper?
- PlexusDx advertises the lower starting price: $99 a month against $149, roughly 1.5× the difference. Whether that is the cheaper purchase depends on what each figure covers: PlexusDx includes medication, and Hims bills it separately.
- What is the difference between PlexusDx and Hims?
- The one that matters: PlexusDx supplies compounded medication (prepared by a compounding pharmacy rather than an FDA-approved product), while Hims supplies FDA-approved drugs only. That is a difference in what arrives, not only in what it costs.
- Which one has more regulatory actions on record?
- Hims, with 4 sourced actions against none found for PlexusDx. Every one is linked to its primary document on the provider's own page. A larger file is not automatically a worse clinic; read what the documents actually say.
Other comparisons: Hims vs Ro (Ro Body) · Hims vs Hers · Hims vs Noom (Noom Med) · Hims vs Calibrate · Hims vs Henry Meds · Hims vs LillyDirect